Загрузка...
Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
BACKGROUND: Stress-associated kinases are considered major pathological mediators in several incurable neurological disorders. Importantly, among these stress kinases, the c-Jun NH2-terminal kinase (JNK) has been linked to numerous neuropathological conditions, including oxidative stress, neuroinfla...
Сохранить в:
| Опубликовано в: : | J Inflamm Res |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770337/ https://ncbi.nlm.nih.gov/pubmed/33384558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S284471 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|